Analysis of the efficacy of upfront brain radiotherapy versus deferred radiotherapy for EGFR/ALK-positive non-small cell lung cancer with brain metastases: a retrospective study

Analysis of the efficacy of upfront brain radiotherapy versus deferred radiotherapy for EGFR/ALK-positive non-small cell lung cancer with brain metastases: a retrospective study

Abstract Background For brain metastases (BMs) from EGFR/ALK-positive non-small cell lung cancer (NSCLC), the best time to administer tyrosine kinase inhibitors (TKIs) and brain radiotherapy (RT) has not been identified. This analysis was an attempt to solve this problem in part. Methods A total of...

Full description

Bibliographic Details
Main Authors: Jing Qian, Zelai He, Ying Wu, Hongwei Li, Qun Zhang, Xianming Li
Format: Article
Language:English
Published: BMC 2024-01-01
Series:BMC Cancer
Subjects:
EGFR
ALK
Non-small cell lung cancer
Radiotherapy
Brain metastases
Online Access:https://doi.org/10.1186/s12885-024-11868-9

Internet

https://doi.org/10.1186/s12885-024-11868-9

Similar Items